North America held a dominan Market position, capturing more than a 38.9% share, holding USD 6.6 Billion revenue.

Illumina unveiled the Billion Cell Atlas, a large‑scale genetic perturbation dataset built with pharma partners to advance AI‑powered drug discovery, target validation, and disease biology.

Chemical biology increasingly benefits from the close integration of experimental structural techniques and computational ...

UN Data serves as a unified platform that brings together statistical data from across the UN system, with the goal of becoming the primary integrated source of trusted UN statistics and data.

Biopharmaceutical artificial intelligence startup Owkin Inc. said today it’s making a series of autonomous agents focused on ...

A data storage strategy that addresses data sovereignty builds on the classification of data in the data audit to limit what data can go where. As part of the classification process, data will be ...

Complementary solutions automate discovery, governance, and enforcement of data sharing and transfer Together with ...

The BFSI industry is a highly regulated sector wherein companies need strong data controls to comply with stringent standards ...

The Kiteworks Private Data Network consumes Microsoft Information Protection (MIP) labels applied by the Concentric AI ...

This year, the e-discovery landscape will likely be marked by the growing prominence of gen AI and court rulings paving the ...

Modern approach to DSPM has one glaringly clear weak spot, neglecting a key aspect of enterprise data usage: the fact that ...

Abstract: The drug discovery process is a complex and resource-demanding enterprise, marked by extended durations and substantial financial investment. Typically, a novel medicinal chemical requires ...